SG2501

· Hangzhou Sumgen Biotech Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SG2501, covering 2025-03-18 to 2025-03-18. Get the full timeline:

Most recent: Clinical Trial Update: SG2501 Safety Study in Subjects with Relapsed or Refractory Hematological Malignancies and Lymphoma. [Phase 1]